ES8503946A1 - Agentes antimicoticos con elevada liberacion del producto activo - Google Patents

Agentes antimicoticos con elevada liberacion del producto activo

Info

Publication number
ES8503946A1
ES8503946A1 ES530845A ES530845A ES8503946A1 ES 8503946 A1 ES8503946 A1 ES 8503946A1 ES 530845 A ES530845 A ES 530845A ES 530845 A ES530845 A ES 530845A ES 8503946 A1 ES8503946 A1 ES 8503946A1
Authority
ES
Spain
Prior art keywords
bifonazole
antimycotic
sprays
solutions
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES530845A
Other languages
English (en)
Spanish (es)
Other versions
ES530845A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES530845A0 publication Critical patent/ES530845A0/es
Publication of ES8503946A1 publication Critical patent/ES8503946A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES530845A 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo Expired ES8503946A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311700 DE3311700A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von loesung und spray

Publications (2)

Publication Number Publication Date
ES530845A0 ES530845A0 (es) 1985-04-16
ES8503946A1 true ES8503946A1 (es) 1985-04-16

Family

ID=6195161

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530845A Expired ES8503946A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539274A Expired ES8601690A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
ES539275A Granted ES539275A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES539274A Expired ES8601690A1 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
ES539275A Granted ES539275A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo

Country Status (18)

Country Link
JP (1) JPS59184125A (pm)
KR (1) KR840008283A (pm)
AU (1) AU564979B2 (pm)
BE (1) BE899277A (pm)
CA (1) CA1212328A (pm)
CH (1) CH660304A5 (pm)
DE (1) DE3311700A1 (pm)
ES (3) ES8503946A1 (pm)
FR (1) FR2543436B1 (pm)
GB (1) GB2137090B (pm)
GR (1) GR81880B (pm)
IL (1) IL71363A0 (pm)
IT (1) IT1173762B (pm)
LU (1) LU85272A1 (pm)
PH (1) PH20964A (pm)
PT (1) PT78312B (pm)
SE (1) SE8401747L (pm)
ZA (1) ZA842336B (pm)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2555555B2 (ja) * 1991-07-03 1996-11-20 武田薬品工業株式会社 抗真菌性外用製剤
US5246716A (en) * 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
WO1997021426A1 (fr) * 1995-12-14 1997-06-19 Taisho Pharmaceutical Co., Ltd. Preparation aerosol
RU2117473C1 (ru) * 1996-05-28 1998-08-20 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии МЗ и ПМ РФ Способ наружного лечения микозов стоп и гладкой кожи
AU2003240301B2 (en) * 2002-06-25 2008-02-14 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
CN118615240B (zh) * 2024-06-24 2024-12-27 江西普丽尔药业有限公司 一种联苯苄唑溶液剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
JPS6018655B2 (ja) * 1976-01-01 1985-05-11 バイエル・アクチエンゲゼルシヤフト アゾリル−(1)−メタン類及びそれらの塩
JPS5598112A (en) * 1979-01-17 1980-07-25 Sumitomo Chem Co Ltd Liquid medicine for external use
DE3019027A1 (de) * 1980-05-19 1981-11-26 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
IL71363A0 (en) 1984-06-29
KR840008283A (ko) 1984-12-14
GB2137090A (en) 1984-10-03
ES530845A0 (es) 1985-04-16
ES8601691A1 (es) 1985-11-16
IT8420304A0 (it) 1984-03-29
FR2543436B1 (fr) 1988-12-16
AU564979B2 (en) 1987-09-03
ES539275A0 (es) 1985-11-16
GR81880B (pm) 1984-12-12
CA1212328A (en) 1986-10-07
DE3311700A1 (de) 1984-10-04
CH660304A5 (de) 1987-04-15
BE899277A (fr) 1984-10-01
PT78312B (en) 1986-06-02
AU2623584A (en) 1984-10-04
FR2543436A1 (fr) 1984-10-05
PH20964A (en) 1987-06-10
SE8401747L (sv) 1984-10-01
LU85272A1 (de) 1984-11-14
PT78312A (en) 1984-04-01
SE8401747D0 (sv) 1984-03-29
ES539274A0 (es) 1985-11-16
ZA842336B (en) 1984-11-28
JPS59184125A (ja) 1984-10-19
GB2137090B (en) 1986-07-09
GB8408066D0 (en) 1984-05-10
IT1173762B (it) 1987-06-24
ES8601690A1 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
TW271395B (pm)
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
IE45256L (en) Quinazolone derivatives
NZ276885A (en) Substituted pyrazolyl-benzenesulphonamide derivatives, preparation and pharmaceutical compositions thereof
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
EP0326357A3 (en) Avermectin derivatives
ES8608535A1 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
IE792241L (en) Hydroxypropyltriazoles
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
NZ196700A (en) Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
ES2144885T3 (es) Empleo como un fungicida de derivados de acido beta-amino-propionico.
ES8601690A1 (es) Un procedimiento para la obtencion de preparados del bifanazol con elevada liberacion del producto actuvo
HU179483B (en) Herbicide and fungicide compositions containing phenoxy-propionic acid derivatives as active agents,and process for producing phenoxy-propionic acid derivatives
HUT64318A (en) Process for production benzodpyrane derivativs and pharmaceutical preparations containing these compounds as effective substance
DE69132578D1 (de) Cephemderivate
DE3062201D1 (en) Antimycotic compositions containing imidazolylenol ethers, their preparation and their use
ES8504434A1 (es) Procedimiento para preparar una composicion fungicida a base de una sal de acido alquil-fosforoso
ES483165A1 (es) Un procedimiento para preparar ureas substituidas.
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
DE69518149D1 (de) Intranasales Antimigränemittel
ES8204980A1 (es) Procedimietno para la preparacion de salicilato de lidocaina monohidrato.
JPS53124267A (en) 1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050212